ArticleCell reports. Medicine2022

Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity.

Huisi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.